Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

G and H Brands Launches Promescent, New Topical on Demand Treatment for Premature Ejaculation


Print article Print article
Refer this article Refer to a friend
© Business Wire 2009
2009-06-08 15:26:19 -

Premature ejaculation : is estimated to affect approximately 30% of the male population, making it more prevalent than erectile dysfunction. Now, men who suffer from this common sexual problem have access to Promescent : a new on-demand topical spray for the treatment of premature ejaculation : .

Promescent : ™ is a

safe and effective lidocaine spray that has been scientifically formulated to treat hypersensitivity of the glans penis, considered to be a key factor in premature ejaculation : (PE.) Developed through major university research under the leadership of board certified urologist Dr. Ronald F. Gilbert and marketed by Calabasas, California-based G and H Brands, LLC., Promescent : ™ represents a significant breakthrough in the treatment of premature ejaculation : .

“ Premature ejaculation : is the most universal form of sexual dysfunction, affecting men of every age. But it is also the least understood,” says Dr. Gilbert, who also serves as President of G and H Brands with co-founder Jody Helfend, CEO. “Embarrassment and lack of accurate information prevent many men from seeking medical treatment for premature ejaculation : , a condition that not only adversely affects them, but also their partners and their relationships. And many of those who do seek treatment are dissatisfied with the therapies that have been available to date.” The most common course of action is the off-label prescription of (Selective Serotonin Re-Uptake Inhibitors) commonly known as anti-depressants, which are costly, have potentially serious side effects, and should be taken every day to maximize efficacy, not just when needed.

Lidocaine -- a topical desensitizer -- was approved by the FDA for the treatment of premature ejaculation : more than 25 years ago and has been proven safe and effective for that purpose. Promescent : ™ is an over-the-counter topical spray containing approximately 10 mg. of lidocaine per spray for the treatment of premature ejaculation : . Promescent : ™ is a safe and effective formulation readily available to the consumer.

By applying a small amount of Promescent : ™ to the head and shaft of the penis 10 – 20 minutes before sexual intercourse, most men will experience significant improvement in their ability to prolong intercourse prior to ejaculation. “Preliminary data indicates that patients are extremely pleased with the results they achieve with Promescent : ™,” says Dr. Gilbert.

Promescent : ™ is sold online through the company’s website ( www.promescent.com : ), over-the-counter and will become available to patients through a direct response television and internet campaign.

Since purchase is easy and completely private, G and H Brands expects an enthusiastic response from the millions of men in the U.S. who suffer from premature ejaculation : . And although no doctor visit is required, Promescent : ™ offers each patient an online consultation with a board certified urologist to determine the individual recommended dosage. Dr. Gilbert will also hold special online office hours to answer patient questions.

An introductory 30-day supply of Promescent : ™ will be offered for $9.99, with each subsequent monthly supply priced at $39.99.

For further information, please visit www.promescent.com : .



G and H Brands is empowering men to regain control over their lives with Promescent : ™, a scientifically formulated desensitizer spray for men suffering from premature ejaculation : . Contact: Customer Support 800-5781699 or for Company information 818.225.5313, jhelfend@promescent.com : mailto:jhelfend@promescent.com .



Kip Morrison & AssociatesKip Morrison, 310-274-6726 kip@kipmorrison.com : mailto:kip@kipmorrison.com


Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com